Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:NVUS

Novus Therapeutics (NVUS) Stock Price, News & Analysis

Novus Therapeutics logo

About Novus Therapeutics Stock (NASDAQ:NVUS)

Advanced Chart

Key Stats

Today's Range
$3.00
$3.13
50-Day Range
$9.85
$16.50
52-Week Range
$4.50
$27.32
Volume
308,590 shs
Average Volume
78,851 shs
Market Capitalization
$4.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NVUS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Novus Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

NVUS Stock News Headlines

Ptc Therapeutics Share Price (PTCT.US)
CAMP4 Therapeutics Corp.
F1 Engineering Powers This Electric Marine Motor
The future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLaren Engineering, a NASDAQ-listed marine tech company unveiled a groundbreaking new electric powertrain set to transform the industry.
Tango Therapeutics Share Price (TNGX.US)
Sarepta Therapeutics Share Price (SRPT.US)
Vivoryon Therapeutics NV VVY
Viking Therapeutics Inc
CYT Cyteir Therapeutics, Inc.
See More Headlines

NVUS Stock Analysis - Frequently Asked Questions

Novus Therapeutics, Inc. (NASDAQ:NVUS) posted its earnings results on Monday, November, 16th. The biopharmaceutical company reported ($5.51) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.64) by $3.87.

Novus Therapeutics shares reverse split on the morning of Monday, October 5th 2020.The 1-18 reverse split was announced on Friday, October 2nd 2020. The number of shares owned by shareholders was adjusted after the market closes on Friday, October 2nd 2020. An investor that had 100 shares of stock prior to the reverse split would have 6 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Novus Therapeutics investors own include SCYNEXIS (SCYX), CymaBay Therapeutics (CBAY), Sorrento Therapeutics (SRNE), Bristol Myers Squibb (BMY), Miragen Therapeutics (MGEN), Selecta Biosciences (SELB) and Tonix Pharmaceuticals (TNXP).

Company Calendar

Last Earnings
11/16/2020
Today
7/07/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:NVUS
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$16.01 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$13.13 per share
Price / Book
0.23

Miscellaneous

Free Float
N/A
Market Cap
$4.42 million
Optionable
Not Optionable
Beta
2.07
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:NVUS) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners